Psoriasis and autoimmune diseases

All Items

• Debut of Psoriasis is usually before Debut of Concomitant Inflammatory Bowel Disease: A Population-based Retrospective Study

  Klas Agerberg, Anders Rönnblom

  adv00714

• Dementia Risk in Psoriasis Patients Treated with Biologics: A Propensity Score-matched Population-based Cohort Study

  Jen A. Barak Levitt, Michael Ziv

  adv43243

• Denosumab-induced Acute Generalized Exanthematous Pustulosis

  Maruška Marovt, Pij B. Marko

  adv40430

• Dermatological Conditions Inducing Acute and Chronic Pain

  Mathilde Hayoun-Vigouroux, Laurent Misery

  adv00742

• Detailed Long-term Dynamics of Neutrophil-to-Lymphocyte Ratio under Biologic Treatment Reveal Differential Effects of Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists

  Jochen H. O. Hoffmann, Christian Knoop, Alexander H. Enk, Eva N. Hadaschik

  adv00568

• Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach

  Carsten Spitzer, Ines Buchholz, Laura Lübke, Clara Wülfing, Katharina Meier, Georgios Kokolakis, Dennis Niebel, Caroline Mann, Ante Karoglan, Steffen Emmert, Alexander Thiem

  adv42794

• Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort

  Tamara W. van Hal, Michelle L.M. Mulder, Mark H. Wenink, Frank H.J. van den Hoogen, Jake S.F. Maurits, Marcel C. Pasch, Juul M.P.A. van den Reek, Elke M.G.J. de Jong

  adv5269

• Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity

  Maike M. Holtsche, Nina van Beek, Takashi Hashimoto, Giovanni Di Zenzo, Detlef Zillikens, Catherine Prost-Squarcioni, Matthias Titeux, Alain Hovnanian, Enno Schmidt, Stephanie Goletz

  adv00420

• Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study

  Laura Gnesotto, Guido Mioso, Federico Bardazzi, Federica Filippi, Vito Di Lernia, Alberico Motolese, Sergio Di Nuzzo, Andrea Conti, Federica Arginelli, Monica Corazza, Giulia Odorici, Alessandro Borghi, Paolo Gisondi, Luigi Naldi, Paolo Dapavo, Aurora Parodi, Martina Burlando, Stefano Piaserico

  adv4526

• Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation

  Chih-Tsung Hung, Chi-Hsiang Chung, Tsu-Hsuan Weng, Chun-Teng Tsai, Wu-Chien Chien, Yung-Lung Chang

  adv44343

• Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort

  Marloes E. van Muijen, Sarah E. Thomas, Hans M.M. Groenewoud, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Sharon R.P. Dodemont, Else N. Kop, Maartje A.M. Berends, Marjolein I.A. Koetsier, Johannes M. Mommers, John E.M. Körver, Ron A. Tupker, Marjolein S. de Bruin-Weller, Lizelotte J.M.T. Weppner-Parren, Bas Peters, Marloes M. Kleinpenning, Astrid L.A. Kuijpers, W. Peter Arnold, Paula P.M. van Lümig, Juul M.P.A. van den Reek, Elke M.G.J. de Jong

  adv00712

• Discontinuation of Fumaric Acid Esters is Affected by Depressive Symptomatology: A Retrospective Analysis

  Frederik Krefting, Stefanie Hölsken, Manfred Schedlowski, Wiebke Sondermann

  adv12326

• Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort

  Tamara W. van Hal, Michelle L.M. Mulder, Mark H. Wenink, Marcel C. Pasch, Frank H.J. van den Hoogen, Juul M.P.A. van den Reek, Elke M.G.J. de Jong

  adv00768

• Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis Models

  Sören Dräger, Thorge Mester, Hermann Tenor, Ralf J. Ludwig, Katja Bieber

  adv41972

• DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis

  Ancor Sanz-Garcia, Alejandra Reolid, Laura H. Fisas, Ester Muñoz-Aceituno, Mar Llamas-Velasco, Antonio Sahuquillo-Torralba, Rafael Botella-Estrada, Jorge García-Martínez, Raquel Navarro, Esteban Daudén, Francisco Abad-Santos, Maria C. Ovejero-Benito

  adv00448

• Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation

  Saori Takamura, Tomoo Fukuda

  adv43999

• Economic Burden of Generalized Pustular Psoriasis: A Population-based Register Study in Finland

  Xavier Teitsma, Laura Huilaja, Mirkka Koivusalo, Juha Mehtälä, Aino Vesikansa, Bregt Kappelhoff, Maria Grönman, Jarmo Kaukua, Pauliina Nuutinen, Rafael Pasternack

  adv44671

• Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study

  Sofia Löfvendahl, Jenny M. Norlin, Marcus Schmitt-Egenolf

  adv00843

• Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid

  Qijun Wang, Yue Ruan, Fei Guo, Haiqin Zhu, Meng Pan

  adv12324

• Effectiveness and Safety of Delgocitinib Cream in Pustulosis Palmoplantaris: A Case Series

  Nikolai Loft, Claus Zachariae, Mette Gyldenløve, Farzad Alinaghi, Diljit Kaur-Knudsen, Lone Skov

  adv44511

• Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study

  Yoshiki Okada, Masahiro Kamata, Kotaro Hayashi, Kazumitsu Sugiura, Yayoi Tada

  adv42879

• Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study

  Giovanna Malara, Cristina Politi, Caterina Trifirò, Chiara Verduci, Graziella D'Arrigo, Alessandra Testa, Giovanni Tripepi

  adv00545

• Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series

  Cecilia Tejero-García, Francesc Alamon Reig, Xavier Bosch-Amate, Cristina Carrera, Priscila Giavedoni, Inmaculada Gil Faure, Alicia Jiménez Antón, Ander Mayor Ibarguren, Teresa Usero Bárcena, Marcial Álvarez-Salafranca, Marta Gamissans Cañada, Joaquín López Robles, Sandra Martínez-Fernández, Sonia Segura, Dolores Sánchez-Aguilar Rojas, Ángeles Flórez

  adv-2026-0588

• Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks

  Elke L. M. ter Haar, Juul M. P. A. van den Reek, Kristian Gaarn Du Jardin, Almudena Barbero-Castillo, Elke M. G. J. de Jong, Satish F. K. Lubeek

  adv17752

• Efficacy and Safety of Tofacitinib in Palmoplantar Pustulosis: A Retrospective Study

  Shuang Lyu, Xiaotong Xue, Na Wang, Hong Liu, Furen Zhang

  adv44083

• Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons

  Yangfeng Ding, Weida Liu

  adv-2025-0183

• Elevated Granulysin Expression in Cytotoxic Lymphocytes from the Blood and Lesions of Patients with Lichen Planus

  Marijana Vičić, Ines Brajac, Marija Kaštelan, Vlatka Sotošek, Larisa Prpić Massari

  adv00499

• Epidemiology of Psoriasis: A Worldwide Global Study

  Charbel Skayem, Charles Taieb, Bruno Halioua, Catherine Baissac, Marketa Saint Aroman

  adv42945

• Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis

  Reinhardt Maximilian, Claudia Garbe, Jana Petersen, Matthias Augustin, Natalia Kirsten, Mona H.C. Biermann, Benjamin M. Häberle, Kristina Hagenström

  adv00566

• Erythema and Blisters in a Patient with Psoriasis: A Quiz

  Jia Tao, Wenlong Hu, Xudong Mu, Hong Ren, Renqiong Chen

  adv40669

• Erythematous Annular and Polycyclic Lesions with Central Hyperpigmentation: A Quiz

  Eglė Janušonytė, Guerkan Kaya, Sébastien Menzinger

  adv42532

• Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

  Selma Atalay, Lara S. van der Schoot, Laura Vandermaesen, Lieke J. van Vugt, Mascha Eilander, Juul M.P.A. van den Reek, Elke M.G.J. de Jong

  adv00463

• Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles

  Jochen H.O. Hoffmann, Christian Knoop, Knut Schäkel, Alexander H. Enk, Eva N. Hadaschik

  adv00462

• Evaluation of the Diagnostic Value of Oesophageal Biopsies for Direct Immunofluorescence Microscopy in Mucous Membrane Pemphigoid

  Kaan Yilmaz, Onur Dikmen, Nina van Beek, Jens U. Marquardt, Martha M. Kirstein, Detlef Zillikens, Enno Schmidt

  adv11947

• Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort

  Thomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, Hugo Arlégui, Carle Paul, Manuelle Viguier, Emmanuel Mahé, Nathalie Beneton, Denis Jullien, Marie-Aleth Richard, Pascal Joly, Florence Tubach, Alain Dupuy, Emilie Sbidian, Olivier Chosidow

  adv00665

• Exploring the Role of Adipose Tissue Dysregulation in Vitiligo Pathogenesis: A Body Composition Analysis

  XinYi Shao, Xingyu Pan, Tingqiao Chen, Ziyan Chen, Yuhao Li, Judan Zhong, Ruiyao Wang, Jun Yu, Jin Chen, Yangmei Chen

  adv41018

• Factors Influencing Major Life-Changing Decisions in Patients with Psoriasis: A Cross-sectional Study

  Manuel Sanchez-Diaz, Pablo Díaz-Calvillo, Alberto Soto-Moreno, Alejandro Molina-Leyva, Salvador Arias-Santiago

  adv11640

• Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and Review of Literature in the Paediatric Population

  Jue Liu, Jianbo Zhong, Qiaowei Wang, Yinglian Cai, Jian Chen

  adv4806

• Forget About Social Determinants when Addressing Adherence to Topical Antipsoriatic Drugs

  Mathias Tiedemann Svendsen, Klaus Ejner Andersen

  adv42698

• Frequency of TNFalpha, IL17RA, and Act1 Genetic Polymorphisms in a Population with Psoriasis Compared with Healthy Individuals: Results in a Multiracial Population in Rio de Janeiro, Brazil

  Ana Luisa Sampaio, Bruna Romana-Souza, Haizza Cristina Cabral de Almeida Monteiro, Camila Oliveira da Silva, Luna Azulay-Abulafia

  adv42017

• From Onset to Outcome: A Long-term Retrospective, Single centre Study of Guttate Psoriasis from Israel

  Riad Kassem, Nofar Edri, Aviv Barzilai, Eran Galili, Anna Lyakhovitsky, Ido Tzanani, Assaf Handelsman, Sharon Baum, Felix Pavlotsky

  adv-2025-0112

• Generalized Pustular Psoriasis with Breast Cancer Successfully Treated with Spesolimab Causing Neutrophilia: A Case Report

  Rina Obata, Mika Yamanaka-Takaichi, Hisayoshi Imanishi, Tomoko Oshimo, Daisuke Tsuruta

  adv42368

• Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center

  Linda Davidson, Juul M.P.A. van den Reek, Florence van Hunsel, Elke M.G.J. de Jong; Bart Jan Kullberg

  adv00648

• Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990–2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021

  Dan Wang, Peizhi Deng, Shengbo Yang, Yangfan Xu, Jianyun Lu

  adv43367

• Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial

  Enikö Sonkoly, Julia-Tatjana Maul, Matteo Megna, Patricia Gorecki, Edmée Crombag, Jozefien Buyze, Laura Savage

  adv18672

• Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

  Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen, Erkki Soini, Riikka Nissinen, Christina Wennerstöm, Tapio Rantanen, Johanna H. Hagman, Rauno Harvima, Johanna Höök-Nikanne, Tiina Ilves, Päivi Lintu, Ken Malanin, Iina Soramäki, Kaisa Tasanen, Arja Teho, Katja Vähävihu, Sari Itälinna, Pekka Leinonen, Piia Sarajärvi, Laura Huilaja, Rafael Pasternack

  adv00631

• Happiness Behind the Scenes: Associations between Heuristic Happiness and Related Dimensions in Skin Diseases

  Johanna Weis, Hannah Wecker, Alexander Arnold, Barbara Schuster, Stefanie Ziehfreund, Linda Tizek, Sonja Mittag, Tilo Biedermann, Alexander Zink

  adv5284

• Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients’ Sweat

  Verena G. Frings, Nadine Roth, Maxine Gläsel, Boris Bauer, Matthias Goebeler, Dagmar Presser, Andreas Kerstan

  adv00793

• Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

  Dana Shalmon, Efrat Bar-Ilan, Alon Peled, Shamir Geller, Jonathan Bar, Naama Schwartz, Eli Sprecher, Mor Pavlovsky

  adv26663

• Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

  April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, Willie I. Visser, Natalie Haustrup, Bruce W. Konicek, Zbigniew Kadziola, Mercedes Nunez, Alan Brnabic, Christopher Schuster

  adv40556